Penczek Ronald W (CAO & Controller) sold 1,531 shares of ELV at $403.13 on 2026-05-19; holds 4,109 shares post-sale
Penczek Ronald W, CAO & Controller, sold 1,531 shares totaling $617,192.03 at $403.13 per share, reducing his position by 27.1%. The transaction occurred near the 52-week high of $412.96, with the stock currently trading at $396.02. His cross-ticker track record shows only 1 prior sell, and his prior trade at ELV (a sell on 2023-11-30) has no measurable outcome yet, providing limited context for assessing timing patterns at this ticker. With Elevance Health trading at a P/E of 16.41 and posting quarterly revenue of $50,181,000,000.00 with net income of $1,764,000,000.00, the company shows solid fundamentals and 12.5% annual revenue growth.